Literature DB >> 5088857

Chemonucleolysis.

I Macnab, J A McCulloch, D S Weiner, E P Hugo, R D Galway, D Dall.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 5088857

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


× No keyword cloud information.
  9 in total

1.  A reappraisal of the diagnosis in cervical disc disease: the posterior longitudinal ligament perforated or not.

Authors:  T Isu; Y Iwasaki; K Miyasaka; H Abe; K Tashiro; T Ito
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

2.  Mechanism of action of intradiscal chymopapain in the treatment of sciatica: a clinical, biochemical, and radiological study.

Authors:  J R Jenner; D J Buttle; A K Dixon
Journal:  Ann Rheum Dis       Date:  1986-06       Impact factor: 19.103

3.  Chemonucleolysis.

Authors:  M M Stephens; F McManus
Journal:  Ir J Med Sci       Date:  1984-05       Impact factor: 1.568

4.  Post-chymopapain (chemonucleolysis)--clinical and computed tomography correlation: preliminary results.

Authors:  J C Mall; J C Kaiser
Journal:  Skeletal Radiol       Date:  1984       Impact factor: 2.199

5.  Chemonucleolysis in the treatment of lumbar disc protrusion.

Authors:  C Sorbie
Journal:  Can Med Assoc J       Date:  1981-04-01       Impact factor: 8.262

6.  Sciatica caused by disc herniation: Why is Chymopapain Chemonucleolysis denied to our patients?

Authors:  Douglas Wardlaw
Journal:  Int J Spine Surg       Date:  2016-12-31

7.  The effect of spondylosis on the outcome of chemonucleolysis.

Authors:  J Tehranzadeh; H H Kaufman; C M Davis; E L Radin
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

8.  Chemonucleolysis for relief of sciatica due to a herniated intervertebral disc.

Authors:  J A McCulloch
Journal:  Can Med Assoc J       Date:  1981-04-01       Impact factor: 8.262

9.  Percutaneous radiofrequency lumbar rhizolysis (rhizotomy).

Authors:  J A McCulloch; L W Organ
Journal:  Can Med Assoc J       Date:  1977-01-08       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.